Learning Objectives:

1. Understand the pre-clinical data suggesting metformin's role as a cancer treatment.

2. Identify the limitations of the current data indicating metformin might be used for cancer.

3. Outline the additional evidence required before implementation into clinical care.



Session date: 
12/11/2017 - 5:00pm to 6:00pm CST
UCMC M-170
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Iris Romero, M.D., M.S.